Innovation

20 patent families (9 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace dormant. Cited 542 times.

Year	Filings
2012	10
2013	8
2014	6
2015	7
2016	7
2017	5
2018	6
2019	2

Investor mix

5 investors on record; lead investors include Vesalius Biocapital Partners, Index Ventures, Gilde Healthcare, Inkef; 1 has since exited.

Investor type	Count	Share
Venture capital	4	80%
Private equity	1	20%